María Dolores Sosa-Reina

Dr. María Dolores Sosa-Reina

Sport Sciences, Universidad Europea, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MSMaría Dolores Sosa-Reina
María Dolores Sosa-Reina
SNSusana Nunez-Nagy
Susana Nunez-Nagy
TGTomás Gallego-Izquierdo
Tomás Gallego-Izquierdo
Daniel Pecos-MartinDaniel Pecos-Martin
Daniel Pecos-Martin
Jorge Monserrat SanzJorge Monserrat Sanz
Jorge Monserrat Sanz
Melchor AlvarezMelchor Alvarez
Melchor Alvarez
Objective. The aim of this study was to summarize evidence on the effectiveness of therapeutic exercise in Fibromyalgia Syndrome. Design. Studies retrieved from the Cochrane Plus, PEDro, and Pubmed databases were systematically reviewed. Randomized controlled trials and meta-analyses involving adults with fibromyalgia were included. The primary outcomes considered in this systematic review were pain, global well-being, symptoms of depression, and health-related quality of life. Results. Effects were summarized using standardized mean differences with 95% confidence intervals using a random effects model. This study provides strong evidence that physical exercise reduces pain (−1.11 [95% CI] −1.52; −0.71; overall effect p<0.001), global well-being (−0.67 [95% CI] −0.89, −0.45; p<0.001), and symptoms of depression (−0.40 [95% CI] −0.55, −0.24; p<0.001) and that it improves both components of health-related quality of life (physical: 0.77 [95% CI] 0.47; 1.08; p<0.001; mental: 0.49 [95% CI] 0.27; 0.71; p<0.001). Conclusions. This study concludes that aerobic and muscle strengthening exercises are the most effective way of reducing pain and improving global well-being in people with fibromyalgia and that stretching and aerobic exercises increase health-related quality of life. In addition, combined exercise produces the biggest beneficial effect on symptoms of depression.

Verified
Journal Article
Open access
PDF file
FGFernando García-Sanz
Fernando García-Sanz
MSMaría Dolores Sosa-Reina
María Dolores Sosa-Reina
GJGonzalo Jaen
Gonzalo Jaen
ÁFÁngel Gonzalez de la Flor
Ángel Gonzalez de la Flor
Jorge Hugo VillafañeJorge Hugo Villafañe
Jorge Hugo Villafañe
Carlos Romero-MoralesCarlos Romero-Morales
Carlos Romero-Morales
Background: Robotic-assisted total knee arthroplasty (rTKA) has been introduced to improve surgical precision and alignment in knee replacement procedures. However, its impact on clinical outcomes, pain relief, and cost-effectiveness remains debated. This umbrella review synthesizes evidence from systematic reviews and meta-analyses comparing rTKA to conventional TKA. Methods: An umbrella review was conducted in PubMed, Scopus, Web of Science, Embase, and the Cochrane Database of Systematic Reviews. Systematic reviews and meta-analyses comparing rTKA with conventional TKA were included. Methodological quality was assessed using AMSTAR 2 and ROBIS tools. Primary outcomes included hospital stay, radiographic alignment, postoperative pain, functional outcomes, and patient satisfaction. Results: Ten systematic reviews were included. rTKA demonstrated superior alignment accuracy and a reduction in alignment outliers. Some studies reported shorter hospital stays and lower early postoperative pain scores for rTKA. However, these benefits did not consistently translate into improved long-term functional outcomes, patient satisfaction, or reduced revision rates. Cost-effectiveness analyses indicated that rTKA remains an expensive option, with benefits largely dependent on surgical volume and healthcare system resources. Conclusions: While rTKA improves surgical precision and may offer short-term advantages, its long-term superiority over conventional TKA remains unproven. Higher costs and longer operative times limit its widespread adoption. Further high-quality, long-term studies are needed to determine its clinical and economic value.

16 December 2024 in Medicina
Verified
Journal Article
Open access
PDF file
AAAlexandra Alonso-Sal
Alexandra Alonso-Sal
JPJosé Luis Alonso Pérez
José Luis Alonso Pérez
MSMaría Dolores Sosa-Reina
María Dolores Sosa-Reina
JGJuan Antonio García-Noblejas-Fernández
Juan Antonio García-Noblejas-Fernández
VBViren Balani
Viren Balani
Jorge Hugo VillafañeJorge Hugo Villafañe
Jorge Hugo Villafañe
Background and Objectives: This systematic review evaluates the effectiveness of exercise interventions for managing nonspecific low back pain (NSLBP) and explores their impact on related biopsychosocial factors, physical health variables, and inflammatory biomarkers. Materials and Methods: A comprehensive search of five databases (PubMed, CINAHL, PEDro, SCOPUS, Cochrane Library) was conducted, covering studies from 2019 to 2024. Fifteen randomized controlled trials involving 1338 participants aged 18 to 65 years with NSLBP were included. Data extraction and quality assessment were performed independently by two reviewers using the PEDro scale, and risk of bias was evaluated using the Cochrane Risk-of-Bias tool (RoB 2.0). Results: Exercise significantly reduced pain intensity and improved biopsychosocial factors such as depression, disability, functionality, quality of life, and kinesiophobia. Additionally, it enhanced physical parameters like proprioception, muscle thickness, and physical performance. However, the review found insufficient evidence regarding the effects of exercise on inflammatory biomarkers in NSLBP patients. Conclusions: The findings suggest that physical exercise is an effective intervention for pain reduction and the improvement of overall health in NSLBP, though further research is needed to clarify its impact on inflammation.

SPSebastián Eustaquio Martín Pérez
Sebastián Eustaquio Martín Pérez
Isidro Miguel Martín PérezIsidro Miguel Martín Pérez
Isidro Miguel Martín Pérez
Eleuterio A. Sánchez RomeroEleuterio A. Sánchez Romero
Eleuterio A. Sánchez Romero
MSMaría Dolores Sosa-Reina
María Dolores Sosa-Reina
AFAlberto Carlos Muñoz Fernández
Alberto Carlos Muñoz Fernández
Jorge Hugo VillafañeJorge Hugo Villafañe
Jorge Hugo Villafañe
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness of the cranial and skeletal muscles, however, neuropathies are extremely rare. In this case report we present a case of a 61-year-old man diagnosed Myasthenia gravis who came to our attention due to a 1 week of acute deep pain [NPRS 8/10] in the anterior and medial right knee which occurred during walking [NPRS 8/10] or stair climbing [NPRS 9/10]. A complete medical record and clinical examination based on physical exploration and ultrasound assessment confirmed a infrapatellar saphenous neuralgia. Therapeutic interventions included Percutaneous nerve electrical stimulation combined with pain neuroscience education, neural mobilization of the saphenous nerve and quadriceps resistance exercises. After 4 weeks, pain intensity [NRPS = 1/10], knee functionality [OKS = 41/48] and lower limb functionality [LLFI = 80%] were notably improved, nevertheless, fatigue [RPE = 2/10] was similar than baseline. At 2 months of follow-up, the effect on intensity of pain NRPS [0/10] and functionality OKS [40/48] and LLFI [82%] was maintained, however, no significant clinical changes were detected on perceived fatigue RPE Scale [2/10]. Despite the important methodological limitations of this study, our case report highlights the efficacy of percutaneous electrical nerve stimulation combined with physical agents modalities for pain and functionality of infrapatellar saphenous neuralgia in the context of Myasthenia gravis.

13 December 2024 in Pain Management Nursing
Verified
Journal Article
Open access
SMSara Mogedano-Cruz
Sara Mogedano-Cruz
MLMaría López-Pérez
María López-Pérez
DGDiego Gijón-Lago
Diego Gijón-Lago
CRCarlos Romero-Morales
Carlos Romero-Morales
JAJosé Luis Alonso-Pérez
José Luis Alonso-Pérez
MSMaría Dolores Sosa-Reina
María Dolores Sosa-Reina
The main objective of this review is to demonstrate the use of Peripheral Percutaneous Electrical Nerve Stimulation (PENS), together with its most up-to-date protocols, for the treatment of neuropathies. We conducted a systematic search for randomised clinical trials evaluating the effectiveness of PENS on pain intensity, sleep quality, oral analgesic intake and depression in patients with neuropathic pain. The search was performed in Pubmed, PEDro and Cochrane databases. The meta-analysis was conducted using RevMan 5.4 software. The mean difference was applied for variables with the same measurement scale, while the standardized mean difference was used for different scales. The inverse variance method was employed for statistical analysis, with heterogeneity assessed using the I² and Cochrane Q statistics. Four articles that met the search requirements were included. After qualitative and quantitative synthesis, the results obtained were an improvement in pain intensity (-3.57 [-4.01, -3.13]; p < .05) and sleep quality (2.48 [1.96, 3.00]; p < .05) and a reduction in medication intake (-2.37 [-4.26, -0.47]; p < .05) and depressive behaviours (-1.10 [-1.55, -0.66]; p < .05). The overall methodological quality was rated as moderate and the risk of bias as unclear. The scientific evidence found is still limited for the use of PENS in neuropathies. However, this study suggests an encouraging future for the use of this therapy as a treatment tool in physiotherapy. PENS requires nurse education on electrode/needle placement and patient instruction, with documentation of key parameters. This review emphasizes the need for further research to establish standardized protocols and optimal application parameters for different neuropathic pain conditions.

8 June 2023 in Geriatrics
Verified
Journal Article
Open access
PDF file
AHAlvaro Lopez Hualda
Alvaro Lopez Hualda
EAElsa Arruti-Pérez
Elsa Arruti-Pérez
FBFátima N. Bebea-Zamorano
Fátima N. Bebea-Zamorano
MSMaría Dolores Sosa-Reina
María Dolores Sosa-Reina
Jorge Hugo VillafañeJorge Hugo Villafañe
Jorge Hugo Villafañe
JMJavier Martínez-Martin
Javier Martínez-Martin
Background: The aim of this study was to compare the clinical outcomes, complications, and mortality of patients with intertrochanteric hip fracture treated with dynamic hip screw (DHS) vs. trochanteric fixation nail advance (TFNA). Methods: We evaluated 152 patients with intertrochanteric fractures concerning age, sex, comorbidity, Charlson Index, preoperative gait, OTA/AO classification, time from fracture to surgery, blood loss, amount of blood replacement, changes in gait, full weight-bearing at hospital discharge, complications, and mortality. The final indicators encompassed the adverse effects linked to implants, postoperative complications, clinical healing or bone healing duration, and functional score. Results: The study included a total of 152 patients, out of which 78 (51%) received DHS treatment and 74 (49%) received TFNA treatment. The results of this study show that the TFNA group demonstrated superiority (p < 0.001). However, it should be noted that the TFNA group had a higher frequency of the most unstable fractures (AO 31 A3, p < 0.005). Full weight-bearing at discharge also decreased in patients with more unstable fractures (p = 0.005) and severe dementia (p = 0.027). Mortality was higher in the DHS group; however, a longer time from diagnosis to surgery was also observed in this group (p < 0.005). Conclusions: The TFNA group has shown a higher success rate in achieving full weight-bearing at hospital discharge when treating trochanteric hip fractures. This makes it the preferred choice for treating unstable fractures in this region of the hip. Additionally, it is important to note that a longer time to surgery is associated with increased mortality in patients with hip fractures.